The GiveWell Blog

Open Philanthropy’s 2023-2025 funding of $300 million total for GiveWell’s recommendations

| by Isabel Arjmand

This year, Open Philanthropy plans to give $300 million for GiveWell to spend over the next three years. We’re grateful for what this support will enable us to do.

Annualized, this is similar to what Open Philanthropy gave in 2020 and roughly in line with what we projected earlier this year. It’s less than Open Philanthropy gave in 2021 and 2022, and we’ll need strong growth in donations in order to make up the difference. We expect to identify more great funding opportunities than we’ll be able to fund, and your support can fill those cost-effective gaps, helping to save and improve people’s lives.

Below, we share:

  • How this update affects GiveWell’s work
  • More background on Open Philanthropy and GiveWell’s relationship
  • Why Open Philanthropy’s spending is changing
  • The impact donors can have by supporting GiveWell’s recommendations

Read more

September 2023 updates

| by Jeremy Rehwaldt

Every month we send an email newsletter to our supporters sharing recent updates from our work. We’ve decided to start publishing selected portions of the newsletter on our blog to make this news more accessible to people who might visit our website. For key updates from the latest installment, please see below!

Read more

September 2023 open thread

| by Miranda Kaplan

Our goal with hosting quarterly open threads is to give blog readers an opportunity to publicly raise comments or questions about GiveWell or related topics (in the comments section below). As always, you’re also welcome to email us at info@givewell.org or to request a call with GiveWell staff if you have feedback or questions you’d prefer to discuss privately. We’ll try to respond promptly to questions or comments.

You can view previous open threads here.

Read more

Why we’re funding clubfoot treatment through MiracleFeet

| by Miranda Kaplan

For many people, GiveWell is practically synonymous with our short list of top charities. But the amount of money we’ve sent to other organizations, doing other important work, has been increasing. In 2021, we made or recommended about $190 million in grants to non–top charity programs, like water treatment and malnutrition treatment, and in 2022, we set up the All Grants Fund specifically so donors could contribute to programs in this category.

We want to use this blog to give you more frequent, brief insights into these newer areas of our grantmaking before we publish our formal grant write-ups. Below we’ll discuss, in light detail, a program that’s well outside of our traditional wheelhouse, but that we think significantly improves children’s lives—treatment for clubfoot with an organization called MiracleFeet.

Read more

June 2023 open thread

| by Miranda Kaplan

Our goal with hosting quarterly open threads is to give blog readers an opportunity to publicly raise comments or questions about GiveWell or related topics (in the comments section below). As always, you’re also welcome to email us at info@givewell.org or to request a call with GiveWell staff if you have feedback or questions you’d prefer to discuss privately. We’ll try to respond promptly to questions or comments.

You can view previous open threads here.

Read more

Why GiveWell funded the rollout of the malaria vaccine

| by Audrey Cooper

Since our founding in 2007, GiveWell has directed over $600 million to programs that aim to prevent malaria, a mosquito-borne disease that causes severe illness and death. Malaria is preventable and curable, yet it killed over 600,000 people in 2021—mostly young children in Africa.

Following the World Health Organization’s approval of the RTS,S/AS01 malaria vaccine (RTS,S) in late 2021, GiveWell directed $5 million to PATH to accelerate the roll out of the vaccine in certain areas of Ghana, Kenya, and Malawi. This grant aimed to enable these communities to gain access to the vaccine about a year earlier than they otherwise would, protecting hundreds of thousands of children from malaria.

Although we’re very excited about the potential of the RTS,S malaria vaccine to save lives, it isn’t a panacea. We still plan to support a range of malaria control interventions, including vaccines, nets, and antimalarial medicine.

In this post, we will:

  • Explain how we found the opportunity to fund the malaria vaccine
  • Discuss why we funded this grant
  • Share our plan for malaria funding moving forward

Read more